Please call your physician’s office before coming in for your appointment if you have symptoms of a cough, fever, or difficulty breathing; traveled to Europe or China or other areas impacted by the coronavirus (COVID-19) within the past 14 days; been in close contact with someone who has traveled outside the U.S. to one of the impacted countries; or may have been exposed to the coronavirus. Effective Monday May 18th all VCS sites will be conducting temperature checks for all patients and visitors at entrances. For your safety, you will be asked to use a mask, if you do not have one, a mask will be provided. If a person presents with a temperature, you will be asked to return home and further instructions will be given by your health care team. For our patients protection, no visitors under 18 will be allowed in the offices, there is a limit one (1) visitor per patient if necessary. No visitors are allowed in the chemo infusion room. FOR THE LATEST UP TO DATE INFORMATION, ALERTS AND CANCELLATIONS PLEASE CLICK HERE

Dr. Patricia Rodriguez speaks at Tigerlily’s 6th Annual Young Women’s Breast Health Day on the Hill

Virginia Cancer Specialists Practice Blog

May 08, 2018
Virginia Cancer Specialists » VCS Practice News » Genetics » VCS Practice News » Genetic Risk Assessment » Dr. Patricia Rodriguez speaks at Tigerlily’s 6th Annual Young Women’s Breast Health Day on the Hill

Tigerlily’s 6th Annual Young Women’s Breast Health Day on the Hill
Ending Disparities Facing Young Women with Breast Cancer

Dr. Patricia Rodriguez, Director of Hereditary Cancer Risk Assessment Program | Virginia Cancer Specialists

Dr. Rodriguez will speak about the importance of hereditary cancer screening and the evolution of companion diagnostics in the treatment of metastatic breast cancer, including the FDAs approval of Myriad’s BRCA test as a companion diagnostic for certain metastatic breast cancer patients.